Evidence map›Paper›PMID 41823255›Full record

ReviewJournal of Parkinson's disease2026

New insights into synaptic vesicle dysfunction in Parkinson's disease.

Julita Chlebowicz, Violetta Ivanova, Jacqueline Burré

Abstract readReview
In one paragraph

Review in Journal of Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Julita ChlebowiczBrain and Mind Research Institute, Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY 10021, USA.ORCID 0000-0002-0437-0338
Violetta IvanovaBrain and Mind Research Institute, Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY 10021, USA.ORCID 0000-0002-6726-3118
Jacqueline BurréBrain and Mind Research Institute, Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY 10021, USA.ORCID 0000-0001-8968-248X

Funding

The impact of synaptic vesicle-binding of alpha-synuclein on neuron function and neuropathologyR01NS113960 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI BURRE, JACQUELINE · 2020 to 2024
$2.4M
The role of VAMP2 in alpha-synuclein function and pathologyR01NS121077 · NINDS · UNIVERSITY OF CINCINNATI · PI BURRE, JACQUELINE, DIAO, JIAJIE · 2021 to 2025
$1.9M
Changes in Synaptic Vesicle-Binding of Alpha-Synuclein as an Early Biomarker for SynucleinopathiesR01NS136423 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Jacqueline Burre, Manu Sharma · 2025 to 2026
$1.6M
The Impact of Beta- and Gamma-Synucleins on Alpha-Synuclein's Synaptic FunctionR01NS126342 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Jacqueline Burre, Manu Sharma · 2025 to 2026
$1.5M
Synaptic vesicle changes in synucleinopathiesR21NS127939 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI BURRE, JACQUELINE · 2022 to 2022
$464k
NINDS NIH HHS R01 NS113960NINDS NIH HHS R01 NS121077NINDS NIH HHS R01 NS126342NINDS NIH HHS R01 NS136423NINDS NIH HHS R21 NS127939
6 · The paper itself

Abstract

Parkinson's disease (PD) is characterized by progressive motor and non-motor dysfunction arising from synaptic pathology that precedes neuronal loss. Synaptic dysfunction represents a central pathological mechanism in both familial and sporadic PD, with multiple PD-linked genes directly regulating synaptic vesicle (SV) trafficking. Here, we review recent studies linking SV dysfunction to PD pathology by examining how disease-linked proteins dysregulate distinct steps in the SV cycle and by exploring their cascading effects on synaptic physiology and circuit function. We highlight three critical pathogenic mechanisms: (1) impaired neurotransmitter import and storage, (2) disrupted SV pool organization, and (3) altered SV exocytosis and endocytosis. We also review recent studies investigating how presynaptic pathology triggers impairments in postsynaptic plasticity and circuit-level reorganization across brain regions. Together, these studies highlight that presynaptic SV dysfunction is a central mechanism in PD pathogenesis and therefore a promising target for developing therapeutic strategies aimed at reverting these early disease-driving synaptic changes.

Indexed as

endocytosisexocytosisneurotransmitter releaseParkinson's diseasesynapsesynaptic vesicle

Identifiers

PMID41823255
PMCPMC13442686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.